Evidence map›Paper›PMID 39120807›Full record

ArticleDiscover nano2024

Ultra-fast photocatalytic degradation of Rhodamine B exploiting oleate-stabilized zinc oxide nanoparticles.

Nicolò Maria Percivalle, Marco Carofiglio, Simelys Hernández, Valentina Cauda

Abstract read
In one paragraph

Article in Discover nano, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nicolò Maria PercivalleDepartment of Applied Science and Technology, Politecnico Di Torino, Corso Duca Degli Abruzzi 24, 10129, Turin, Italy.
Marco CarofiglioDepartment of Applied Science and Technology, Politecnico Di Torino, Corso Duca Degli Abruzzi 24, 10129, Turin, Italy.
Simelys HernándezDepartment of Applied Science and Technology, Politecnico Di Torino, Corso Duca Degli Abruzzi 24, 10129, Turin, Italy. simelys.hernandez@polito.it.
Valentina CaudaDepartment of Applied Science and Technology, Politecnico Di Torino, Corso Duca Degli Abruzzi 24, 10129, Turin, Italy. valentina.cauda@polito.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rhodamine B (RhB) is a harmful dye released by industrial wastewaters, thus necessitating its urgent removal. Advanced oxidation processes constitute promising strategies to purify polluted water. Among others, photocatalysis relies on reactive oxygen species (ROS) produced by photocatalytic particles, typically semiconductors like titania or zinc oxide (ZnO), excited by solar or UV-Vis light. However, their wide band gap limits their catalytic capabilities within the absorption of the UV spectrum and causes fast electron-hole recombination. This study presents novel strategies to overcome these limitations: (i) doping semiconductors to increase photocatalytic efficiency; (ii) sensitization-mediated photocatalysis for visible light activation using chemical moieties to trap dye molecules; (iii) nanosizing the photocatalysts to enhance the surface area. ZnO nanoparticles, doped with iron or gadolinium and capped with oleic acid are here synthesized and tested in RhB dye solutions. Remarkably, the results demonstrate an ultra-fast RhB degradation, driven by oleic acid having crucial role in dye adsorption. The degradation mechanisms, including ROS-induced N-deethylation and xanthene group cleavage, are also unraveled. These findings underscore the efficacy of the proposed semiconductor photocatalyst design, highlighting a significant advancement with extensive potential applications in wastewater remediation. This innovative approach paves the way for more efficient and practical solutions to combat industrial dye pollution.

Indexed as

Capping agentDopingPhotodegradationROSZinc oxide

Identifiers

PMID39120807
PMCPMC11315820

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.